Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial

Leuk Lymphoma. 2025 Jul;66(7):1342-1345. doi: 10.1080/10428194.2025.2475338. Epub 2025 Mar 11.
No abstract available

Keywords: CD123; Tagraxofusp; blastic plasmacytoid dendritic cell neoplasm; hematologic malignancies; phase1/2; prior/concomitant.